HIF1A and lung cancer: In xenograft models of different human cancers, such as hepatoma, cervical carcinoma, and lung cancer, YC-1 significantly inhibited tumor growth and prolonged the survival periods, associating with reduced HIF-1α expression and blocked angiogenesis [23,24].